Dachaigh › Cancer Ovarian › California › Mountain View
Sgrùdaidhean clionaigeach Cancer Ovarian ann an Mountain View, CA
Tha 19 sgrùdaidhean airson Cancer Ovarian a’ lorg phàirtichean aig làraichean ann agus timcheall air Mountain View (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
A’ fastadhÌre 2/3
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mìle air falbh
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
A’ fastadhÌre 2
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mìle air falbh
- VA Palo Alto Health Care System, Palo Alto · 5 mìle air falbh
A Study of PHST001 in Advanced Solid Tumors
A’ fastadhÌre 1
- Stanford University School of Medicine, Palo Alto · 5 mìle air falbh
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
A’ fastadhSgrùdadh amharc
- Stanford University, Palo Alto · 5 mìle air falbh
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A’ fastadhÌre 3
- Stanford Women's Cancer Center, Palo Alto · 5 mìle air falbh
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
A’ fastadhÌre 1
- Stanford University Medical Center, Stanford · 5 mìle air falbh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
A’ fastadhÌre 1/2
- Stanford Cancer Institute, Stanford · 5 mìle air falbh
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
A’ fastadhÌre 1
- Stanford University, Palo Alto · 5 mìle air falbh
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
A’ fastadhÌre 1
- Stanford, Palo Alto · 5 mìle air falbh
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
A’ fastadhÌre 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mìle air falbh
- agus 1 a bharrachd
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
A’ fastadhÌre 2
- 150, Palo Alto · 5 mìle air falbh
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
A’ fastadhÌre 3
- Palo Alto Medical Foundation, Palo Alto · 5 mìle air falbh
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
A’ fastadhÌre 1/2
- Stanford University, Stanford · 5 mìle air falbh
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
A’ fastadhÌre 1/2
- Stanford Women's Cancer Center, Palo Alto · 5 mìle air falbh
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
A’ fastadhSgrùdadh amharc
- Stanford University School of Medicine, Stanford · 5 mìle air falbh
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
A’ fastadhÌre 1/2
- Stanford Cancer Institute, Stanford · 5 mìle air falbh
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
A’ fastadhÌre 3
- Stanford Ambulatory Surgery Center Lane Operating Room, Palo Alto · 5 mìle air falbh
- Stanford Women's Cancer Center, Palo Alto · 5 mìle air falbh
- Stanford Hospital, Palo Alto · 5 mìle air falbh
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
A’ fastadhÌre 2
- Stanford Cancer Center, Palo Alto · 5 mìle air falbh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Stanford · 5 mìle air falbh
Sgrùdaidhean Cancer Ovarian ann am bailtean eile
- Houston, TX89 sgrùdaidhean
- New York City, NY69 sgrùdaidhean
- Boston, MA61 sgrùdaidhean
- Los Angeles, CA50 sgrùdaidhean
- Nashville, TN49 sgrùdaidhean
- Arlington, VA46 sgrùdaidhean
- Philadelphia, PA44 sgrùdaidhean
- Columbus, OH39 sgrùdaidhean
- St. Louis, MO38 sgrùdaidhean
- Chicago, IL36 sgrùdaidhean
- San Antonio, TX31 sgrùdaidhean
- Cleveland, OH30 sgrùdaidhean
Sgrùdaidhean eile ann an Mountain View
- Aillse (gach seòrsa)40 sgrùdaidhean
- Aillse a' bhroilleach26 sgrùdaidhean
- Ailse metastatach25 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag21 sgrùdaidhean
- Leukemia myeloid geur19 sgrùdaidhean
- Galar Speactram Autism17 sgrùdaidhean
- Ailseachadh nan Sgamhan17 sgrùdaidhean
- Aillse Prostata15 sgrùdaidhean
- Fàilligeadh a' Chridhe15 sgrùdaidhean
- Autism13 sgrùdaidhean
- Leukemia lymphoblastic geur13 sgrùdaidhean
- Aillse colorectal13 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.